124 related articles for article (PubMed ID: 24044568)
21. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
Kon CH; Occleston NL; Aylward GW; Khaw PT
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery.
Tseng W; Cortez RT; Ramirez G; Stinnett S; Jaffe GJ
Am J Ophthalmol; 2004 Jun; 137(6):1105-15. PubMed ID: 15183797
[TBL] [Abstract][Full Text] [Related]
23. Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders.
Abu el-Asrar AM; Van Damme J; Put W; Veckeneer M; Dralands L; Billiau A; Missotten L
Am J Ophthalmol; 1997 May; 123(5):599-606. PubMed ID: 9152065
[TBL] [Abstract][Full Text] [Related]
24. Cytokine gene polymorphisms in retinal detachment patients with and without proliferative vitreoretinopathy: a preliminary study.
Sanabria Ruiz-Colmenares MR; Pastor Jimeno JC; Garrote Adrados JA; Telleria Orriols JJ; Yugueros Fernández MI
Acta Ophthalmol Scand; 2006 Jun; 84(3):309-13. PubMed ID: 16704689
[TBL] [Abstract][Full Text] [Related]
25. High TGF-beta2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy.
Dieudonné SC; La Heij EC; Diederen R; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4113-8. PubMed ID: 15505063
[TBL] [Abstract][Full Text] [Related]
26. [Surgical treatment of progressive and symptomatic retinal detachment in senile retinoschisis].
Dotrelová D
Sb Lek; 2002; 103(2):109-31. PubMed ID: 12688133
[TBL] [Abstract][Full Text] [Related]
27. Clinical complications of Densiron 68 intraocular tamponade for complicated retinal detachment.
Li W; Zheng J; Zheng Q; Wu R; Wang X; Xu M
Eye (Lond); 2010 Jan; 24(1):21-8. PubMed ID: 19325573
[TBL] [Abstract][Full Text] [Related]
28. Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment.
Ricker LJ; Kijlstra A; de Jager W; Liem AT; Hendrikse F; La Heij EC
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4143-50. PubMed ID: 20335622
[TBL] [Abstract][Full Text] [Related]
29. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
Wang ZY; Shen LJ; Zhao KK; Song ZM; Qu J
Ophthalmic Res; 2009; 42(3):138-40. PubMed ID: 19602911
[TBL] [Abstract][Full Text] [Related]
30. Biomarkers for PVR in rhegmatogenous retinal detachment.
Zandi S; Pfister IB; Traine PG; Tappeiner C; Despont A; Rieben R; Skowronska M; Garweg JG
PLoS One; 2019; 14(4):e0214674. PubMed ID: 30943234
[TBL] [Abstract][Full Text] [Related]
31. Pars plana vitrectomy with medium-term postoperative perfluoro-N-octane for recurrent inferior retinal detachment complicated by advanced proliferative vitreoretinopathy.
Sigler EJ; Randolph JC; Calzada JI; Charles S
Retina; 2013 Apr; 33(4):791-7. PubMed ID: 23117281
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and surgical management of familial exudative vitreoretinopathy-associated rhegmatogenous retinal detachment.
Chen SN; Hwang JF; Lin CJ
Retina; 2012 Feb; 32(2):220-5. PubMed ID: 22277905
[TBL] [Abstract][Full Text] [Related]
33. [Heavy tamponade in complicated inferior retinal detachment].
Brunner M; Lang C; Valmaggia C
Klin Monbl Augenheilkd; 2012 Apr; 229(4):407-10. PubMed ID: 22496014
[TBL] [Abstract][Full Text] [Related]
34. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
35. Prediction of proliferative vitreoretinopathy after retinal detachment surgery: potential of biomarker profiling.
Ricker LJ; Kessels AG; de Jager W; Hendrikse F; Kijlstra A; la Heij EC
Am J Ophthalmol; 2012 Aug; 154(2):347-354.e2. PubMed ID: 22541653
[TBL] [Abstract][Full Text] [Related]
36. High-speed, high-resolution spectral optical coherence tomography in patients after vitrectomy with internal limiting membrane peeling for proliferative vitreoretinopathy retinal detachment.
Odrobina DC; Michalewska Z; Michalewski J; Nawrocki J
Retina; 2010 Jun; 30(6):881-6. PubMed ID: 20182404
[TBL] [Abstract][Full Text] [Related]
37. Pediatric rhegmatogenous retinal detachment in East Asians.
Wang NK; Tsai CH; Chen YP; Yeung L; Wu WC; Chen TL; Lin KK; Lai CC
Ophthalmology; 2005 Nov; 112(11):1890-5. PubMed ID: 16271317
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 and matrix metalloproteinase expression in the subretinal fluid during proliferative vitreoretinopathy: correlation with extent, duration of RRD and PVR grade.
Symeonidis C; Papakonstantinou E; Androudi S; Tsaousis KT; Tsinopoulos I; Brazitikos P; Karakiulakis G; Diza E; Dimitrakos SA
Cytokine; 2012 Jul; 59(1):184-90. PubMed ID: 22579111
[TBL] [Abstract][Full Text] [Related]
39. Prevention and control of proliferative vitreoretinopathy: primary retinal detachment surgery using silicone oil as a planned two-stage procedure in high-risk cases.
Alexander P; Prasad R; Ang A; Poulson AV; Scott JD; Snead MP
Eye (Lond); 2008 Jun; 22(6):815-8. PubMed ID: 17277751
[TBL] [Abstract][Full Text] [Related]
40. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
